Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,380 across all filing types
Latest filing 2015-06-23 Capital/Financing Update
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2015 SECOND TRANCHE OF SUPER-SHORT-TERM BONDS
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of the issuance of a tranche of super-short-term bonds by Yanzhou Coal Mining Company Limited. It references regulatory compliance with the Securities and Futures Ordinance and listing rules of the Hong Kong Stock Exchange. The content details the bond issuance amount, terms, interest rate, and registration approvals. The document is relatively short (3938 characters) and focuses on providing the outcome of a financing activity rather than a full financial report or detailed analysis. It is not an annual or interim report, nor a management discussion or earnings release. It is clearly an update on a capital raising event, specifically a bond issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2015-06-23 English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2015 FIRST TRANCHE OF SUPER-SHORT-TERM BONDS
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of the issuance of a tranche of super-short-term bonds by Yanzhou Coal Mining Company Limited. It details the amount issued, terms, interest rate, and other issuance specifics. The document references prior approvals and registration notices related to financing activities. It is not a full financial report but an update on a capital raising activity. The document length is 3803 characters, which is relatively short and focused on the issuance event. Therefore, it fits the category of Capital/Financing Update (CAP) rather than a full Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement or regulatory filing as it contains substantive details about the issuance itself.
2015-06-16 English
THIRD ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Capital/Financing Update Classification · 95% confidence The document is an announcement made pursuant to disclosure requirements under Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. It relates to a general mandate granted to the board to repurchase H shares of the company and informs creditors about the process to claim creditor's rights in relation to this repurchase. The document is titled as an "Overseas Regulatory Announcement" and is primarily a notification to creditors about the repurchase mandate and the procedure for claims. It does not contain financial statements, audit information, or detailed financial results. It is not a report but an announcement related to capital structure changes (share repurchase). Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 5388 characters, which is sufficient for a substantive announcement rather than a brief notice. Confidence is high given the clear content and regulatory references.
2015-06-11 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2015-06-10 English
SECOND ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Regulatory Filings Classification · 95% confidence The document is an announcement related to a general mandate granted to the board to repurchase H shares of the company. It informs creditors about their rights to claim against the company in relation to this repurchase mandate. The document references a previous announcement and provides instructions for creditors to submit claims. It is regulatory in nature, related to compliance with listing rules and company law, but does not contain financial statements, detailed financial data, or management discussion. It is not a report itself but an announcement regarding a corporate action and creditor notification. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2015-06-10 English
ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to disclosure requirements under Rule 13.10B of the Hong Kong Stock Exchange listing rules. It informs creditors about the general mandate granted to the board to repurchase H shares and provides instructions for creditors to submit claims. The content focuses on the announcement of the repurchase mandate and creditor notification rather than financial results, management changes, or detailed financial data. The document is about a regulatory announcement related to share repurchase authorization and creditor claims, not a report or detailed financial statement. It is not a full financial report, earnings release, or management discussion. The document length is about 5,156 characters, which is relatively short and primarily an announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2015-06-08 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.